Skip to main content
Clinical Trials/NCT01484938
NCT01484938CompletedNot Applicable

Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers

Alcon Research2 sites in 1 country175 target enrollmentStarted: February 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
175
Locations
2
Primary Endpoint
Mean Change From Baseline (Day 0) in Average Corneal Staining Area at Day 30

Study Overview

Brief Summary

The purpose of this study was to describe mean differences in corneal staining (type and area) for OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS) at Day 30 compared to Baseline (Day 0).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years or older
  • Soft contact lens wear on a daily wear basis
  • Able to wear contact lenses for at least 8 hours
  • Generally healthy and have normal ocular health
  • Other protocol-defined inclusion criteria may apply

Exclusion Criteria

  • No use of additional lens cleaners
  • No known sensitivities to any ingredient in the test article
  • No history of ocular surgery/trauma within the last six months
  • Other protocol-defined exclusion criteria may apply

Outcomes

Primary Outcomes

Mean Change From Baseline (Day 0) in Average Corneal Staining Area at Day 30

Time Frame: Baseline (Day 0), Day 30

Percentage corneal staining was assessed by the investigator for each of five regions of the cornea; i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Percentage corneal staining was recorded in increments of ten, and the percentages of the five regions were averaged together.

Mean Change From Baseline (Day 0) in Total Corneal Staining Type at Day 30

Time Frame: Baseline (Day 0), Day 30

Corneal staining type was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0=none; 1=micropunctate; 2=macropunctate; 3=coalesced macropunctate; 4=patch (\>/= 1 mm). The five regions were summed, for a summed total range of 0-20.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Lens Wearing Experience and... | Clinical Trial